Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRANSACT2: Artemether-Lumefantrine vs Mefloquine-Artesunate for Uncomplicated Malaria
NCT01939886Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Apr 2013
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of artesunate + mefloquine in malaria (2 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Clinical and Parasitological Treatment Failure at 42 days. Started Apr 2013; status: completed.
02
Drugs
artesunate + mefloquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT01939886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01939886.